EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Feasibility of Administering the Patient Reported Outcomes, Burdens and Experiences (PROBE) Questionnaire Through the Canadian Bleeding Disorders Registry (CBDR) and Comparison of Data From the Two Sources

Federico Germini, Carlo Cossa iD, Elisabetta Trinari, Emma Iserman, Quazi Ibrahim, Drashti Pete, Arun Keepanasseril iD, David Page iD, Mark W Skinner iD, Alfonso Iorio iD

Haemophilia · 2025

DOI: 10.1111/hae.70117 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Haemophilia, 2025. Verfasst von Federico Germini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology & Thromboembolism, and Health Information Research Unit (HIRU), McMaster University, Hamilton, Ontario…. Hauptthemen laut MEDLINE: Registries, Patient Reported Outcome Measures, Hemophilia A. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire can be used to measure quality of life in persons with haemophilia (PWH) and is integrated in the Canadian Bleeding Disorders Registry (CBDR). This offers the opportunity to compare the same data inputted by patients in PROBE and their treating team in CBDR.

Aim

Our objectives were to assess the feasibility of collecting PROBE data through CBDR and to compare the data collected from these two sources.

Methods

We conducted a prospective observational study among PWH using MyCBDR. Participants were invited to digitally complete the PROBE questionnaire at baseline and to repeat it at 6 and 12 months. Additional data were passively collected through CBDR. Data from PROBE and CBDR were compared using Kappa agreement, intraclass correlation (ICC) and Pearson correlation.

Results

A total of 142 PWH participated. Recruitment ratios were 21.1% and 12.0% for the two phases. Retention rates were 40.8% at 6 months and 32.4% at 12 months. Three hundred thirteen subjects were involved in the comparison between PROBE and CBDR data. The agreement was good to very good ( κ > 0.75) or the correlation very strong, with the exception of the history of inhibitor ( κ = 0.57), recent bleeds ( κ = 0.48) and current treatment regimen ( κ = 0.57).

Conclusion

The integration of PROBE with CBDR is feasible and PROBE is a reliable tool for routine PRO data collection. Its use in clinical practice may improve data quality and personalized and patient‐centred care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesPatient Reported Outcome MeasuresHemophilia AHumansCanadaSurveys and QuestionnairesMaleAdultFeasibility StudiesQuality of LifeProspective StudiesMiddle AgedFemaleAdolescentYoung Adult

Stichwörter der Autor:innen

CBDRPROPROBEhaemophiliapatient‐reported outcomesroutine data collection

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology & Thromboembolism, and Health Information Research Unit (HIRU), McMaster University, Hamilton, Ontario, Canada.
  • Clinical Epidemiology and Research Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Humanitas University, Pieve Emanuele, Milan, Italy.
  • Division of Developmental Pediatrics, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Department of Health Evidence, Research, and Impact (HEI), Health Research Information Unit (HIRU), McMaster University, Hamilton, Ontario, Canada.
  • Canadian Hemophilia Society, Montreal, Québec, Canada.

ORCID-Profile: Carlo Cossa, Arun Keepanasseril, David Page, Mark W Skinner, Alfonso Iorio

Förderung

  • Roche

Zitieren

APA

Germini, F., Cossa, C., Trinari, E., Iserman, E., Ibrahim, Q., Pete, D., Keepanasseril, A., Page, D., Skinner, M. W., & Iorio, A. (2025). Feasibility of Administering the Patient Reported Outcomes, Burdens and Experiences (PROBE) Questionnaire Through the Canadian Bleeding Disorders Registry (CBDR) and Comparison of Data From the Two Sources. Haemophilia. https://doi.org/10.1111/hae.70117

Vancouver

Germini F, Cossa C, Trinari E, Iserman E, Ibrahim Q, Pete D, et al. Feasibility of Administering the Patient Reported Outcomes, Burdens and Experiences (PROBE) Questionnaire Through the Canadian Bleeding Disorders Registry (CBDR) and Comparison of Data From the Two Sources. Haemophilia. 2025. doi:10.1111/hae.70117

BibTeX
@article{Germini2025,
  author = {Germini, Federico and Cossa, Carlo and Trinari, Elisabetta and Iserman, Emma and Ibrahim, Quazi and Pete, Drashti and Keepanasseril, Arun and Page, David and Skinner, Mark W and Iorio, Alfonso},
  title = {Feasibility of Administering the Patient Reported Outcomes, Burdens and Experiences (PROBE) Questionnaire Through the Canadian Bleeding Disorders Registry (CBDR) and Comparison of Data From the Two Sources},
  journal = {Haemophilia},
  year = {2025},
  doi = {10.1111/hae.70117}
}
Kostenlos starten →